![](/img/cover-not-exists.png)
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
Katayama, Ryohei, Gong, Bo, Togashi, Noriko, Miyamoto, Masaya, Kiga, Masaki, Iwasaki, Shiho, Kamai, Yasuki, Tominaga, Yuichi, Takeda, Yasuyuki, Kagoshima, Yoshiko, Shimizu, Yuki, Seto, Yosuke, Oh-haraVolume:
10
Language:
english
Journal:
Nature Communications
DOI:
10.1038/s41467-019-11496-z
Date:
December, 2019
File:
PDF, 2.83 MB
english, 2019